Moving forward with breast cancer prevention
نویسندگان
چکیده
منابع مشابه
Moving Forward in Human Cancer Risk Assessment
BACKGROUND The current safety paradigm for assessing carcinogenic properties of drugs, cosmetics, industrial chemicals, and environmental exposures relies mainly on in vitro genotoxicity testing followed by 2-year rodent bioassays. This testing battery is extremely sensitive but has low specificity. Furthermore, rodent bioassays are associated with high costs, high animal burden, and limited pr...
متن کاملMoving forward in HIV-associated cancer.
Cancer has been linked to HIV since the earliest days of the epidemic. The unusually frequent occurrence of Kaposi sarcoma (KS) among men who have sex with men (MSM) in 1981 was a sentinel observation leading to the inclusion of KS in the first AIDS case definition. More than three decades later, major research investments have led to striking advances in understanding HIV pathogenesis, with an...
متن کاملCancer vaccines: moving toward prevention?
After several decades of research, recent successful phase III controlled clinical trials have renewed enthusiasm for vaccine treatment of cancer. This perspective on the report by Berta and colleagues in this issue of the journal (beginning on page 994) discusses the potential prevention of oral cancer through vaccine strategies and, in the broader context, ideal characteristics of tumor antig...
متن کاملCancer prevention through a precautionary approach to environmental chemicals: policy and research recommendations for moving forward.
1. Primary prevention of cancer: great potential, little progress Progress on the prevention of cancers caused by chemical hazards in the workplace and general environment has fallen far short of what is feasible. I will discuss three main reasons for this: 1) public funds dedicated to primary cancer prevention are inadequate; 2) the process of identifying carcinogens in the environment and reg...
متن کاملMoving Forward
.......Having reached the end of my second term as editor in chief, the time has come for Micro to move forward to the next phase of its evolution. I am delighted to announce that Dr. Erik Altman from IBM Research is the new Micro EIC. Erik is an accomplished and highly respected industry architect and researcher who has held numerous leadership positions within the computing community. He has ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 2007
ISSN: 0008-543X,1097-0142
DOI: 10.1002/cncr.22711